OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Suetonia C. Palmer, Britta Tendal, Reem A. Mustafa, et al.
BMJ (2021), pp. m4573-m4573
Open Access | Times Cited: 485
Suetonia C. Palmer, Britta Tendal, Reem A. Mustafa, et al.
BMJ (2021), pp. m4573-m4573
Open Access | Times Cited: 485
Showing 1-25 of 485 citing articles:
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 698
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 698
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 680
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 680
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Ildiko Lingvay, Priya Sumithran, Ricardo V. Cohen, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 394-405
Closed Access | Times Cited: 374
Ildiko Lingvay, Priya Sumithran, Ricardo V. Cohen, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 394-405
Closed Access | Times Cited: 374
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S158-S190
Open Access | Times Cited: 346
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S158-S190
Open Access | Times Cited: 346
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 257
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 257
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Chengxu Ma, Xiaoni Ma, Conghui Guan, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 236
Chengxu Ma, Xiaoni Ma, Conghui Guan, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 236
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Peter Stenvinkel, Glenn M. Chertow, Prasad Devarajan, et al.
Kidney International Reports (2021) Vol. 6, Iss. 7, pp. 1775-1787
Open Access | Times Cited: 180
Peter Stenvinkel, Glenn M. Chertow, Prasad Devarajan, et al.
Kidney International Reports (2021) Vol. 6, Iss. 7, pp. 1775-1787
Open Access | Times Cited: 180
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S179-S218
Open Access | Times Cited: 178
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S179-S218
Open Access | Times Cited: 178
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
Qingyang Shi, Kailei Nong, Per Olav Vandvik, et al.
BMJ (2023), pp. e074068-e074068
Open Access | Times Cited: 167
Qingyang Shi, Kailei Nong, Per Olav Vandvik, et al.
BMJ (2023), pp. e074068-e074068
Open Access | Times Cited: 167
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S144-S174
Open Access | Times Cited: 165
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S144-S174
Open Access | Times Cited: 165
Insulin resistance and insulin sensitizing agents
Lucia Mastrototaro, Michael Roden
Metabolism (2021) Vol. 125, pp. 154892-154892
Open Access | Times Cited: 163
Lucia Mastrototaro, Michael Roden
Metabolism (2021) Vol. 125, pp. 154892-154892
Open Access | Times Cited: 163
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
Haiqiang Yao, Anqi Zhang, Delong Li, et al.
BMJ (2024), pp. e076410-e076410
Open Access | Times Cited: 157
Haiqiang Yao, Anqi Zhang, Delong Li, et al.
BMJ (2024), pp. e076410-e076410
Open Access | Times Cited: 157
Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3587-3587
Open Access | Times Cited: 149
Kazufumi Nakamura, Toru Miyoshi, Masashi Yoshida, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3587-3587
Open Access | Times Cited: 149
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
Calvin Ke, K.M. Venkat Narayan, Juliana C.N. Chan, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 413-432
Open Access | Times Cited: 148
Calvin Ke, K.M. Venkat Narayan, Juliana C.N. Chan, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 7, pp. 413-432
Open Access | Times Cited: 148
Insulin resistance and cardiovascular disease
Constantine E. Kosmas, Maria D. Bousvarou, Christina Kostara, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 3
Open Access | Times Cited: 133
Constantine E. Kosmas, Maria D. Bousvarou, Christina Kostara, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 3
Open Access | Times Cited: 133
Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis
Απόστολος Τσάπας, Thomas Karagiannis, Panagiota Kakotrichi, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 9, pp. 2116-2124
Closed Access | Times Cited: 127
Απόστολος Τσάπας, Thomas Karagiannis, Panagiota Kakotrichi, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 9, pp. 2116-2124
Closed Access | Times Cited: 127
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
Bo Xu, Shaoqian Li, Bo-Kyeong Kang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 116
Bo Xu, Shaoqian Li, Bo-Kyeong Kang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 116
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 101
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 101
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
Alison K. Wright, Matthew Carr, Evangelos Kontopantelis, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 909-918
Open Access | Times Cited: 100
Alison K. Wright, Matthew Carr, Evangelos Kontopantelis, et al.
Diabetes Care (2022) Vol. 45, Iss. 4, pp. 909-918
Open Access | Times Cited: 100
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 1, pp. 25-45
Open Access | Times Cited: 62
Rachel Sinha, Dimitris Papamargaritis, Jack A. Sargeant, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 1, pp. 25-45
Open Access | Times Cited: 62
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
Karly C. Sourris, Yi Ding, Scott Maxwell, et al.
Kidney International (2023) Vol. 105, Iss. 1, pp. 132-149
Open Access | Times Cited: 51
Karly C. Sourris, Yi Ding, Scott Maxwell, et al.
Kidney International (2023) Vol. 105, Iss. 1, pp. 132-149
Open Access | Times Cited: 51
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 46
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 46
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
R. I. G. Holt, Clive S. Cockram, Ronald C.W., et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1168-1180
Open Access | Times Cited: 41
R. I. G. Holt, Clive S. Cockram, Ronald C.W., et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1168-1180
Open Access | Times Cited: 41
